We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Ticker | Name | Price | Change | Change % | Volume | Trades |
---|---|---|---|---|---|---|
FRSOA | Forrestania Resources Ltd | 0.002 | 0.001 | 100.00% | 140,000 | 1 |
BMOOA | Bastion Minerals Limited | 0.002 | 0.001 | 100.00% | 253,500 | 1 |
REEO | RareX Limited | 0.002 | 0.001 | 100.00% | 338,954 | 3 |
LITOA | Lithium Australia Ltd | 0.007 | 0.003 | 75.00% | 6 | 1 |
NHEOA | Noble Helium Ltd | 0.01 | 0.003 | 42.86% | 1,252,974 | 10 |
AEV | Avenira Limited | 0.007 | 0.002 | 40.00% | 5,129,194 | 74 |
REE | RareX Limited | 0.02 | 0.0055 | 37.93% | 16,994,818 | 219 |
PKO | Peako Limited | 0.004 | 0.001 | 33.33% | 125,000 | 1 |
BFC | Beston Global Food Company Limited | 0.004 | 0.001 | 33.33% | 1,997,249 | 12 |
JAV | Javelin Minerals Ltd | 0.002 | 0.0005 | 33.33% | 425,491 | 4 |
ECT | Environmental Clean Technologies Limited | 0.004 | 0.001 | 33.33% | 309,161 | 15 |
Final Conversion of $18 Million in Convertible Debt Occurred Today Greenwave Eliminated an Additional $17.2 Million in Debt Held by Chairman Company Now Has No Convertible Debt or Preferred Shares Outstanding Greenwave Bolsters Balance Sheet with $21.8 Million in Cash CHESAPEAKE, Va., May 22, 2024 /PRNewswire/ -- Greenwave Technology Solutions, Inc. ("Greenwave" or the "Company") (Nasdaq: GWAV), an operator of metal recycling facilities in Virginia, North Carolina, and Ohio, today announced that it has retired all of its convertible debt and preferred shares. Since the beginning of 2024, Greenwave has eliminated $35.2 million in debt, including $17.2 million of debt ...
Bicycle Therapeutics plc (NASDAQ: BCYC), a pharmaceutical company pioneering a new and differentiated class of therapeutics based on its proprietary bicyclic peptide (Bicycle®) technology, today announced that the company has entered into a securities purchase agreement with certain existing and new accredited investors to issue and sell an aggregate of 25,933,706 American Depositary Shares (“ADSs”), each representing one ordinary share, and in lieu of ADSs to investors that so choose, non-voting ordinary shares, each at a price of $21.42 per share, through a private investment in public equity (“PIPE”) financing. Bicycle anticipates the gross proceeds from the PIPE to be ...
Tango Therapeutics, Inc. (NASDAQ: TNGX), a clinical-stage biotechnology company committed to discovering and delivering the next generation of precision cancer medicines, today announced that it will discontinue development of its TNG348 program.
Data Will be Presented in Two Posters at the EASL Congress 2024 CAMBRIDGE, Mass., May 22, 2024 /PRNewswire/ -- NeuroBo Pharmaceuticals, Inc. (Nasdaq: NRBO), a clinical-stage biotechnology company focused on the transformation of cardiometabolic diseases, today announced that pre-clinical data suggests that DA-1241, a novel G-Protein-Coupled Receptor 119 (GPR119) agonist, in combination with semaglutide (Wegovy®), improves liver fibrosis and demonstrates additive hepatoprotective effects in pre-clinical metabolic dysfunction-associated steatohepatitis (MASH) models compared to either treatment alone. Members of the Dong-A ST Research Center and Contract Research Organization, Gubra, will present the data in two poster presentations at the EASL Congress 2024, ...
Ticker | Name | Price | Change | Change % | Market Cap | Volume |
---|---|---|---|---|---|---|
BTC | Bitcoin | 69,902.86 | 799.84 | 1.16% | 1.37T | 3,371,381,871 |
ETH | Ethereum | 3,921.98 | 184.57 | 4.94% | 470.59B | 4,198,047,342 |
USDT | Tether USD | 0.99947 | -0.00004 | 0.00% | 97.79B | 223,438,028 |
BNB | Binance Coin | 612.13 | -2.20 | -0.36% | 96.77B | 301,996,622 |
SOL | Solana | 175.99 | -0.960 | -0.54% | 77.41B | 1,205,846,322 |
STETH | stETH | 3,924.06 | 188.89 | 5.06% | 38.39B | 3,882,619 |
XRP | Ripple | 0.5285 | 0.0019 | 0.36% | 28.86B | 260,066,247 |
USDC | USD Coin | 1.00 | 0.0001 | 0.01% | 28.07B | 1,208,571,734 |
DOGE | Dogecoin | 0.16829 | 0.00194 | 1.17% | 24.19B | 417,942,217 |
TONCOIN | Wrapped TON Coin | 6.47 | -0.071423 | -1.09% | 22.7B | 114,143,937 |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions